National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M.
Brawley OW, et al.
Ann Intern Med. 2008 Jun 17;148(12):932-8. doi: 10.7326/0003-4819-148-12-200806170-00220. Epub 2008 May 5.
Ann Intern Med. 2008.
PMID: 18458271
Free article.
No abstract available.